MétaCan
Menu
Back to cohort
Record W2123889466 · doi:10.1038/bjc.2012.160

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

2012· article· en· W2123889466 on OpenAlexafffund
Anna Jakubowska, Dominik Rozkrut, Antonis C. Antoniou, Ute Hamann, Rodney J. Scott, L McGuffog, S Healy, Olga M. Sinilnikova, Gad Rennert, Flavio Lejbkowicz, Anath Flugelman, Irene L. Andrulis, Gord Glendon, H Ozçelik, Mads Thomassen, M Paligo, Paolo Aretini, J Kantala, B Aroer, Anna von Wachenfeldt, Annelie Liljegren, Niklas Loman, Kenneth D. Herbst, Ulf Kristoffersson, Richard Rosenquist, Per Karlsson, Marie Stenmark‐Askmalm, Beatrice Melin, Katherine L. Nathanson, Susan M. Domchek, Tomasz Byrski, Tomasz Huzarski, Jacek Gronwald, Janusz Menkiszak, Cezary Cybulski, P. Sanchez-Serrano, Ana Osório, Teresa Ramóny Cajal, Marianthi Tsitlaidou, Javier Benı́tez, Michael Gilbert, Matti A. Rookus, Cora M. Aalfs, Irma Kluijt, J L Boessenkool-Pape, Hanne Meijers‐Heijboer, Jan C. Oosterwijk, Christi J. van Asperen, Marinus J. Blok, Marcel Nelen, A.M.W. van den Ouweland, Caroline Seynaeve, Rob B. van der Luijt, Peter Devilee, Douglas F. Easton, S. Peock, D Frost, Radka Platte, Steve D. Ellis, Elena Fineberg, D. Gareth Evans, Fiona Lalloo, Rosalind A. Eeles, Chris Jacobs, Julian Adlard, R. Davidson, Diana Eccles, T Cole, Jackie Cook, Andrew K. Godwin, Betsy Bove, Dominique Stoppa‐Lyonnet, Virginie Caux‐Moncoutier, Muriel Belotti, Carole Tirapo, Sylvie Mazoyer, Laure Barjhoux, Nadia Boutry‐Kryza, Pascal Pujol, Isabelle Coupier, JP Peyrat, Philippe Vennin, D Müller, J.-P. Fricker, Laurence Venat‐Bouvet, Oskar T. Johannsson, Claudine Isaacs, Rita K. Schmutzler, Barbara Wappenschmidt, A Meindl, Norbert Arnold, Raymonda Varon-Mateeva, Dieter Niederacher, Christian Sutter, Heidrun L. Deissler, Sabine Preisler-Adams, Jacques Simard, Penny Soucy, Francine Durocher, Georgia Chenevix‐Trench, Jonathan Beesley, X. Chen, Timothy R. Rebbeck, Fergus J. Couch, X. Wang, Noralane M. Lindor, Zachary Fredericksen, V. Shane Pankratz, Paolo Peterlongo, Bernardo Bonanni, Stefano Fortuzzi, Bernard Peissel, Csilla I. Szabo, P. L., Jennifer T. Loud, Jan Lubiński

Bibliographic record

VenueBritish Journal of Cancer · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalCancer Care OntarioCentre hospitalier universitaire de QuébecLunenfeld-Tanenbaum Research Institute
FundersNational Cancer InstituteCanadian Institutes of Health ResearchNational Institutes of HealthSahlgrenska UniversitetssjukhusetCancer Care OntarioAkademiska SjukhusetOdense UniversitetshospitalMayo ClinicIstituto Toscano TumoriLunds UniversitetZonMwMinisterio de Ciencia e InnovaciónNational Institute for Health and Care ResearchUppsala UniversitetCancer AustraliaNational Health and Medical Research CouncilCancer Research UKUniversity of PennsylvaniaSusan G. KomenDeutsches KrebsforschungszentrumRoyal Marsden NHS Foundation TrustMedical Research CouncilBreast Cancer Research FoundationNational Breast Cancer Foundation
KeywordsMethylenetetrahydrofolate reductaseOvarian cancerBreast cancerOncologyGenotypeMutationMedicineInternal medicineGeneticsCancer researchGynecologyBiologyCancerGene

Abstract

fetched live from OpenAlex

BACKGROUND: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methylene-tetrahydrofolate reductase (MTHFR), both of which are important either directly or indirectly in maintaining genomic integrity. METHODS: To evaluate the potential role of genetic variants within PHB and MTHFR in breast and ovarian cancer risk, 4102 BRCA1 and 2093 BRCA2 mutation carriers, and 6211 BRCA1 and 2902 BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) were genotyped for the PHB 1630 C>T (rs6917) polymorphism and the MTHFR 677 C>T (rs1801133) polymorphism, respectively. RESULTS: There was no evidence of association between the PHB 1630 C>T and MTHFR 677 C>T polymorphisms with either disease for BRCA1 or BRCA2 mutation carriers when breast and ovarian cancer associations were evaluated separately. Analysis that evaluated associations for breast and ovarian cancer simultaneously showed some evidence that BRCA1 mutation carriers who had the rare homozygote genotype (TT) of the PHB 1630 C>T polymorphism were at increased risk of both breast and ovarian cancer (HR 1.50, 95%CI 1.10-2.04 and HR 2.16, 95%CI 1.24-3.76, respectively). However, there was no evidence of association under a multiplicative model for the effect of each minor allele. CONCLUSION: The PHB 1630TT genotype may modify breast and ovarian cancer risks in BRCA1 mutation carriers. This association need to be evaluated in larger series of BRCA1 mutation carriers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.080
Threshold uncertainty score0.997

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.253
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations37
Published2012
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicBRCA gene mutations in cancerFrench-language works237,207